Angela C. Hirbe, Ph.D. - Publications

Affiliations: 
2009 Washington University, Saint Louis, St. Louis, MO 
Area:
Cell Biology, Oncology

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Hirbe AC, Dahiya S, Friedmann-Morvinski D, Verma IM, Clapp DW, Gutmann DH. Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation. Oncotarget. PMID 26859681 DOI: 10.18632/Oncotarget.7232  0.52
2015 Hirbe AC, Dahiya S, Miller CA, Li T, Fulton RS, Zhang X, McDonald S, DeSchryver K, Duncavage EJ, Walrath J, Reilly KM, Abel HJ, Pekmezci M, Perry A, Ley TJ, et al. Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 25925892 DOI: 10.1158/1078-0432.Ccr-14-3049  0.52
2015 Epstein JA, Ingram DA, Hirbe AC, Gutmann DH. A multidisciplinary approach in neurofibromatosis 1-Authors' reply The Lancet Neurology. 14: 30-31. PMID 25496893 DOI: 10.1016/S1474-4422(14)70298-4  0.52
2015 Pekmezci M, Reuss DE, Hirbe AC, Dahiya S, Gutmann DH, von Deimling A, Horvai AE, Perry A. Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 187-200. PMID 25189642 DOI: 10.1038/Modpathol.2014.109  0.52
2014 Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. The Lancet. Neurology. 13: 834-43. PMID 25030515 DOI: 10.1016/S1474-4422(14)70063-8  0.52
2014 Hirbe AC, Pekmezci M, Dahiya S, Apicelli AJ, Van Tine BA, Perry A, Gutmann DH. BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Neuro-Oncology. 16: 466-7. PMID 24366910 DOI: 10.1093/Neuonc/Not248  0.52
2013 Frith AE, Hirbe AC, Van Tine BA. Novel pathways and molecular targets for the treatment of sarcoma. Current Oncology Reports. 15: 378-85. PMID 23661264 DOI: 10.1007/S11912-013-0319-3  0.52
2012 Su X, Floyd DH, Hughes A, Xiang J, Schneider JG, Uluckan O, Heller E, Deng H, Zou W, Craft CS, Wu K, Hirbe AC, Grabowska D, Eagleton MC, Townsley S, et al. The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling. The Journal of Clinical Investigation. 122: 3579-92. PMID 22996695 DOI: 10.1172/Jci38576  0.52
2009 Hirbe AC, Roelofs AJ, Floyd DH, Deng H, Becker SN, Lanigan LG, Apicelli AJ, Xu Z, Prior JL, Eagleton MC, Piwnica-Worms D, Rogers MJ, Weilbaecher K. The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts. Bone. 44: 908-16. PMID 19442620 DOI: 10.1016/J.Bone.2009.01.010  0.52
2008 Vaira S, Johnson T, Hirbe AC, Alhawagri M, Anwisye I, Sammut B, O'Neal J, Zou W, Weilbaecher KN, Faccio R, Novack DV. RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proceedings of the National Academy of Sciences of the United States of America. 105: 3897-902. PMID 18322009 DOI: 10.1073/Pnas.0708576105  0.52
2008 Uluçkan O, Eagleton MC, Floyd DH, Morgan EA, Hirbe AC, Kramer M, Dowland N, Prior JL, Piwnica-Worms D, Jeong SS, Chen R, Weilbaecher K. APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice. Journal of Cellular Biochemistry. 104: 1311-23. PMID 18260128 DOI: 10.1002/Jcb.21709  0.52
2008 Apicelli AJ, Maggi LB, Hirbe AC, Miceli AP, Olanich ME, Schulte-Winkeler CL, Saporita AJ, Kuchenreuther M, Sanchez J, Weilbaecher K, Weber JD. A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function. Molecular and Cellular Biology. 28: 1068-80. PMID 18070929 DOI: 10.1128/Mcb.00484-07  0.52
2007 Hirbe AC, Rubin J, Uluçkan O, Morgan EA, Eagleton MC, Prior JL, Piwnica-Worms D, Weilbaecher KN. Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone. Proceedings of the National Academy of Sciences of the United States of America. 104: 14062-7. PMID 17715292 DOI: 10.1073/Pnas.0705203104  0.52
2007 Hirbe AC, Uluçkan O, Morgan EA, Eagleton MC, Prior JL, Piwnica-Worms D, Trinkaus K, Apicelli A, Weilbaecher K. Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood. 109: 3424-31. PMID 17192391 DOI: 10.1182/Blood-2006-09-048686  0.52
2005 Gauvain KM, Garbow JR, Song SK, Hirbe AC, Weilbaecher K. MRI detection of early bone metastases in B16 mouse melanoma models Clinical and Experimental Metastasis. 22: 403-411. PMID 16283483 DOI: 10.1007/S10585-005-1264-9  0.52
2001 Gutmann DH, Hirbe AC, Haipek CA. Functional analysis of neurofibromatosis 2 (NF2) missense mutations Human Molecular Genetics. 10: 1519-1529. PMID 11448944 DOI: 10.1093/Hmg/10.14.1519  0.52
2001 Gutmann DH, Hirbe AC, Huang ZY, Haipek CA. The Protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion Neurobiology of Disease. 8: 266-278. PMID 11300722 DOI: 10.1006/Nbdi.2000.0376  0.52
1999 Gutmann DH, Zhang Y, Hirbe A. Developmental regulation of a neuron-specific neurofibromatosis 1 isoform Annals of Neurology. 46: 777-782. PMID 10553997 DOI: 10.1002/1531-8249(199911)46:5<777::Aid-Ana15>3.0.Co;2-H  0.52
1999 Strauss BL, Gutmann DH, Dehner LP, Hirbe A, Zhu X, Marley EF, Liapis H. Molecular analysis of malignant triton tumors. Human Pathology. 30: 984-8. PMID 10452514 DOI: 10.1016/S0046-8177(99)90255-1  0.52
Show low-probability matches.